SCHEMBL3604443

SCHEMBL3604443

Nc1ccccc1NC(=O)Cc1csc(N(Cc2c(F)c(F)c(F)c(F)c2F)C(=O)O)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
MAPT P10636 5/20 0.39
HDAC3 O15379 3/20 0.39
GAA P10253 2/20 0.39
PDE5A O76074 2/20 0.39
KDM4E B2RXH2 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
ALDH1A1 P00352 4/20 0.38
HPGD P15428 1/20 0.38
GFER P55789 1/20 0.38
LMNA P02545 2/20 0.38
ALOX12 P18054 1/20 0.38
HDAC1 Q13547 2/20 0.37
HDAC2 Q92769 2/20 0.37
NCOR2 Q9Y618 1/20 0.37
TSHR P16473 1/20 0.37
HTT P42858 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC7 Q8WUI4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3607234 0.86 HDAC3 (0.45) MEN1KMT2AMAPTHDAC3GAA
SCHEMBL3608603 0.83 HDAC3 (0.42) MEN1KMT2AMAPTHDAC3GAA
SCHEMBL3609508 0.83 GSTO1 (0.47) MAPTHDAC3GAAALDH1A1LMNA
SCHEMBL3607165 0.81 PKM (0.42) MEN1KMT2AMAPTHDAC3GAA
SCHEMBL3604448 0.78 KDM4E (0.38) MEN1KMT2AMAPTHDAC3GAA
SCHEMBL3604446 0.77 MAPT (0.39) MEN1KMT2AMAPTHDAC3GAA
SCHEMBL8246351 0.74 GAA (0.49) MEN1KMT2AMAPTHDAC3GAA
SCHEMBL3618263 0.73 PDE5A (0.39) HDAC3GAAPDE5AKDM4EALDH1A1
SCHEMBL3597144 0.73 SMN1; SMN2 (0.57) MEN1KMT2AMAPTGAAPDE5A
SCHEMBL3604243 0.73 MEN1 (0.48) MEN1KMT2AMAPTSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100152188-A1 Novel Heterocyclic Compounds ORCHID RESEARCH LABORATORIES LIMITED (IN) 2010-06-17 US claimed
US-20100152188-A1 Novel Heterocyclic Compounds ORCHID RESEARCH LABORATORIES LIMITED (IN) 2010-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152188-A1 Novel Heterocyclic Compounds CYP11B2, CYP3A5, CYP11B1 MEN1 116/4885KMT2A 4019/4885MAPT 2986/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.